Clovis Oncology, Inc. Finance Lease, Interest Expense
Clovis Oncology, Inc. reported Finance Lease, Interest Expense of $363.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinanceLeaseInterestExpense · last filed 2022-11-09
- Clovis Oncology, Inc. finance lease, interest expense for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Clovis Oncology, Inc. finance lease, interest expense for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Clovis Oncology, Inc. finance lease, interest expense for the quarter ending 2021-06-30 was $178.00K, a 14.42% decline year-over-year.
- Clovis Oncology, Inc. finance lease, interest expense for the quarter ending 2021-03-31 was $185.00K, a 13.95% decline year-over-year.
- Clovis Oncology, Inc. finance lease, interest expense for fiscal 2021 was $363.00K, a 55.51% decline from fiscal 2020.
- Clovis Oncology, Inc. finance lease, interest expense for fiscal 2020 was $816.00K, a 7.51% increase from fiscal 2019.
- Clovis Oncology, Inc. finance lease, interest expense for fiscal 2019 was $759.00K.
| Period end | Finance Lease, Interest Expense 3 month | Finance Lease, Interest Expense 6 month | Finance Lease, Interest Expense 9 month | Finance Lease, Interest Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $178.00K derived: sum of 3 quarters · filed 2022-11-09 | $363.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $178.00K derived: sum of 2 quarters · filed 2022-11-09 | $363.00K 10-Q · filed 2022-11-09 | $555.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $178.00K 10-Q · filed 2022-08-08 | $363.00K 10-Q · filed 2022-08-08 | $555.00K derived: sum of 3 quarters · filed 2022-08-08 | $756.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $185.00K 10-Q · filed 2022-05-05 | $377.00K derived: sum of 2 quarters · filed 2022-05-05 | $578.00K derived: sum of 3 quarters · filed 2022-05-05 | $786.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $393.00K derived: sum of 2 quarters · filed 2022-02-24 | $601.00K derived: sum of 3 quarters · filed 2022-02-24 | $816.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $201.00K 10-Q · filed 2021-11-03 | $409.00K derived: sum of 2 quarters · filed 2021-11-03 | $624.00K 10-Q · filed 2021-11-03 | $846.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $208.00K 10-Q · filed 2021-08-04 | $423.00K 10-Q · filed 2021-08-04 | $645.00K derived: sum of 3 quarters · filed 2022-02-24 | $819.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $215.00K 10-Q · filed 2021-05-05 | $437.00K derived: sum of 2 quarters · filed 2022-02-24 | $611.00K derived: sum of 3 quarters · filed 2022-02-24 | $790.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $396.00K derived: sum of 2 quarters · filed 2022-02-24 | $575.00K derived: sum of 3 quarters · filed 2022-02-24 | $759.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $174.00K 10-Q · filed 2020-11-05 | $353.00K derived: sum of 2 quarters · filed 2020-11-05 | $537.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $179.00K 10-Q · filed 2020-08-07 | $363.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $184.00K 10-Q · filed 2020-05-06 |